The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Polymer conjugates as anticancer nanomedicines
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Self-citationNanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Design and development of polymers for gene delivery
Pack, D. W., Hoffman, A. S., Pun, S., & Stayton, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1775 · Cited by 2,568
Chemotherapy and the war on cancer
Chabner, B. A., & Roberts, T. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1529 · Cited by 2,154
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Brem, H., Piantadosi, S., Burger, P. C., Walker, M., Selker, R., Vick, N. A., Black, K., Sisti, M., Brem, S., Mohr, G., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90755-6 · Cited by 1,389
Dendrimers and dendritic polymers in drug delivery
Gillies, E. R., & Fréchet, J. M. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03276-3 · Cited by 1,367
Westphal, M., Hilt, D. C., Bortey, E., Delavault, P., Olivares, R., Warnke, P. C., Whittle, I. R., Jääskeläinen, J., & Ram, Z. (2003) · Neuro-Oncology · doi:10.1093/neuonc/5.2.79 · Cited by 1,330
Dendrimer biocompatibility and toxicity
DUNCAN, R., & IZZO, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.019 · Cited by 1,158
Self-citationStructure and properties of pharmacologically active polymers
Ringsdorf, H. (1975) · Journal of Polymer Science: Polymer Symposia · doi:10.1002/polc.5070510111 · Cited by 1,094
Kukowska-Latallo, J. F., Candido, K. A., Cao, Z., Nigavekar, S. S., Majoros, I. J., Thomas, T. P., Balogh, L. P., Khan, M. K., & Baker, J. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3921 · Cited by 912
Block copolymer micelles as vehicles for drug delivery
Kazunori, K., Glenn S., K., Masayuki, Y., Teruo, O., & Yasuhisa, S. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90172-2 · Cited by 877
Effective drug delivery by PEGylated drug conjugates
Greenwald, R. B., Choe, Y. H., McGuire, J., & Conover, C. D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00180-1 · Cited by 869
Bae, Y., Nishiyama, N., Fukushima, S., Koyama, H., Yasuhiro, M., & Kataoka, K. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0498166 · Cited by 742
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
Self-citationEncyclopedia of molecular cell biology and molecular medicine
Meyers, R. A. (2004) · Cited by 613
HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of action
Kopecek, J. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00075-8 · Cited by 562
Polymeric anticancer drugs with pH-controlled activation
Ulbrich, K. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.040 · Cited by 494
Drug-polymer conjugates: potential for improved chemotherapy
Duncan, R. (1992) · Anti-Cancer Drugs · doi:10.1097/00001813-199206000-00001 · Cited by 444
Self-citationSeymour, L. W., Duncan, R., Strohalm, J., & Kopeček, J. (1987) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820211106 · Cited by 436
Self-citationHepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
The uses and properties of PEG-linked proteins.
Delgado, C., Francis, G. E., & Fisher, D. (1992) · PubMed · Cited by 420
Wang, Y.-S., Youngster, S., Grace, M., Bausch, J., Bordens, R., & Wyss, D. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00027-3 · Cited by 420
Dendrimer-platinate: a novel approach to cancer chemotherapy.
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · PubMed · Cited by 417
Self-citationDendrimer-platinate: a novel approach to cancer chemotherapy
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199909000-00010 · Cited by 402
Self-citationDanson, S., Ferry, D., Alakhov, V, Margison, J., Kerr, D., Jowle, D., Brampton, M., Halbert, G., & Ranson, M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601856 · Cited by 382
Antibody-targeted radiation cancer therapy
Milenic, D. E., Brady, E. D., & Brechbiel, M. W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1413 · Cited by 380
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
Satchi-Fainaro, R., Puder, M., Davies, J. W., Tran, H. T., Sampson, D. A., Greene, A. K., Corfas, G., & Folkman, J. (2004) · Nature Medicine · doi:10.1038/nm1002 · Cited by 345
Advancing the field of drug delivery
Moses, M. A., Brem, H., & Langer, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00276-9 · Cited by 343
Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide
Dharap, S. S., Wang, Y., Chandna, P., Khandare, J. J., Qiu, B., Gunaseelan, S., Sinko, P. J., Stein, S., Farmanfarmaian, A., & Minko, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504274102 · Cited by 340
Li, C., Yu, D. F., Newman, R. A., Cabral, F., Stephens, L. C., Hunter, N. R., Milas, L., & Wallace, S. (1998) · PubMed · Cited by 340
Seymour, L. W., Miyamoto, Y., Maeda, H., Brereton, M., Strohalm, J., Ulbrich, K., & Duncan, R. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00514-6 · Cited by 337
Self-citationWhat's wrong with our cancer models?
Kamb, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1635 · Cited by 335
Heil, G., Hoelzer, D., Sanz, M. A., Lechner, K., Liu Yin, J. A., Papa, G., Noens, L., Szer, J., Ganser, A., O'Brien, C., et al. (1997) · Blood · doi:10.1182/blood.v90.12.4710 · Cited by 332
Pegaspargase: a review of clinical studies
Graham, M. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00110-8 · Cited by 322
Design and Chemical Synthesis of a Homogeneous Polymer-Modified Erythropoiesis Protein
Kochendoerfer, G. G., Chen, S.-Y., Mao, F., Cressman, S., Traviglia, S., Shao, H., Hunter, C. L., Low, D. W., Cagle, E. N., Carnevali, M., et al. (2003) · Science · doi:10.1126/science.1079085 · Cited by 312
Folate receptor-targeted drugs for cancer and inflammatory diseases
Low, P. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.003 · Cited by 306
Holmes, F. A., Jones, S. E., O’Shaughnessy, J., Vukelja, S., George, T., Savin, M., Richards, D., Glaspy, J., Meza, L., Cohen, G., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf130 · Cited by 291
Masayuki, Y., Mizue, M., Noriko, Y., Teruo, O., Yasuhisa, S., Kazunori, K., & Shohei, I. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90139-k · Cited by 290
Iwai, K., Maeda, H., & Konno, T. (1984) · PubMed · Cited by 284
The Design and Development of Pegfilgrastim (PEG-rmetHuG-CSF, Neulasta®)
Molineux, G. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043452613 · Cited by 283
Meerum Terwogt, J. M., ten Bokkel Huinink, W. W., Schellens, J. H., Schot, M., Mandjes, I. A., Zurlo, M. G., Rocchetti, M., Rosing, H., Koopman, F. J., & Beijnen, J. H. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200104000-00003 · Cited by 279
Davis, F. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00021-2 · Cited by 278
Katre, N. V., Knauf, M. J., & Laird, W. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.6.1487 · Cited by 244
Minko, T., Kopečková, P., Pozharov, V., & Kopeček, J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00009-1 · Cited by 243
Use of peginterferon alfa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C
Rajender Reddy, K., Modi, M. W., & Pedder, S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00028-5 · Cited by 241
The clinical efficacy of poly(ethylene glycol)-modified proteins
Fuertges, F., & Abuchowski, A. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90127-f · Cited by 226
Rademaker-Lakhai, J. M., Terret, C., Howell, S. B., Baud, C. M., de Boer, R. F., Pluim, D., Beijnen, J. H., Schellens, J. H. M., & Droz, J.-P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0315 · Cited by 214
Paclitaxel poliglumex (XYOTAX™, CT-2103): A macromolecular taxane
Singer, J. W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.033 · Cited by 213
Polymer Therapeutics Designed for a Combination Therapy of Hormone‐Dependent Cancer
Vicent, M. J., Greco, F., Nicholson, R. I., Paul, A., Griffiths, P. C., & Duncan, R. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200462960 · Cited by 199
Self-citationDuncan, R., Cable, H. C., Lloyd, J. B., Rejmanová, P., & Kopeček, J. (1983) · Die Makromolekulare Chemie · doi:10.1002/macp.1983.021841005 · Cited by 193
Self-citationPreclinical evaluation of polymer-bound doxorubicin
Duncan, R., Seymour, L. W., O'Hare, K. B., Flanagan, P. A., Wedge, S., Hume, I. C., Ulbrich, K., Strohalm, J., Subr, V., Spreafico, F., et al. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90088-9 · Cited by 187
Self-citationGianasi, E., Wasil, M., Evagorou, E. G., Keddle, A., Wilson, G., & Duncan, R. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00030-1 · Cited by 186
Self-citationJulyan, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00124-2 · Cited by 180
Polymer–drug conjugates: towards a novel approach for the treatment of endrocine-related cancer
Duncan, R., Vicent, M. J., Greco, F., & Nicholson, R. I. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01045 · Cited by 179
Self-citationInhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin
Satchi-Fainaro, R., Mamluk, R., Wang, L., Short, S. M., Nagy, J. A., Feng, D., Dvorak, A. M., Dvorak, H. F., Puder, M., Mukhopadhyay, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.007 · Cited by 173
Singer, J. W., Baker, B., de Vries, P., Kumar, A., Shaffer, S., Vawter, E., Bolton, M., & Garzone, P. D. (2004) · Advances in experimental medicine and biology · doi:10.1007/0-306-47932-x_6 · Cited by 168
Seymour, L., Ulbrich, K., Steyger, P., Brereton, M., Subr, V, Strohalm, J., & Duncan, R. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.363 · Cited by 164
Self-citationŘíhová, B. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00404-8 · Cited by 162
Site-Directed Pegylation of Recombinant Interleukin-2 at its Glycosylation Site
Goodson, R. J., & Katre, N. V. (1990) · Nature Biotechnology · doi:10.1038/nbt0490-343 · Cited by 159
Antibody-targeted chemotherapy with immunoconjugates of calicheamicin
Damle, N. K. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00083-3 · Cited by 155
Kattan, J. G., Droz, J., Couvreur, P., Marino, J. P., Boutan-Laroze, A., Rougier, P. R., Brault, P., Vranckx, H., Grognet, J., Morge, X., et al. (1992) · Investigational New Drugs · doi:10.1007/bf00877245 · Cited by 153
Abshire, T. C., Pollock, B. H., Billett, A. L., Bradley, P., & Buchanan, G. R. (2000) · Blood · doi:10.1182/blood.v96.5.1709 · Cited by 152
Synthesis and in Vivo Antitumor Activity of Poly( l -glutamic acid) Conjugates of 20(S)-Camptothecin
Bhatt, R., de Vries, P. W., Tulinsky, J., Bellamy, G., Baker, B., Singer, J. W., & Klein, P. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020022r · Cited by 152
Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD)
Danhauser-riedl, S., Hausmann, E., Schick, H.-D., Bender, R., Dietzfelbinger, H., Rastetter, J., & Hanauske, A.-R. (1993) · Investigational New Drugs · doi:10.1007/bf00874153 · Cited by 152
Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane
Singer, J. W., Shaffer, S. A., Baker, B., Bernareggi, A., Stromatt, S. C., Nienstedt, D., & Besman, M. (2005) · Anti-Cancer Drugs · doi:10.1097/00001813-200503000-00003 · Cited by 149
Polymer Therapeutics for Cancer: Current Status and Future Challenges
Satchi‐Fainaro, R., Duncan, R., & Barnés, C. M. (2005) · Springer eBooks · doi:10.1007/12_024 · Cited by 146
Self-citationProtein, peptide and non-peptide drug PEGylation for therapeutic application
Pasut, G., Guiotto, A., & Veronese, F. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.6.859 · Cited by 145
PDEPT: polymer-directed enzyme prodrug therapy
Satchi, R., Connors, T. A., & Duncan, R. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2026 · Cited by 132
Self-citationRowinsky, E. K., Rizzo, J. D., Ochoa, L., Takimoto, C. H. M., Forouzesh, B., Schwartz, G. H., Hammond, L. A., Patnaik, A., Kwiatek, J., Goetz, A. D., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.143 · Cited by 132
Duncan, R., Kopec̆ek, J., Rejmanová, P., & Lloyd, J. B. (1983) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(83)90258-1 · Cited by 127
Self-citationBissett, D., Cassidy, J., Bono, J. S. D., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601922 · Cited by 125
Sabbatini, P. J., Aghajanian, C. A., Dizon, D. S., Anderson, S., Dupont, J., Brown, J. V., Peters, W. A., Jacobs, A. D., Mehdi, A., Rivkin, S. E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.043 · Cited by 125
Gene Delivery Using Polymer Therapeutics
Wagner, E., & Kloeckner, J. (2006) · Springer eBooks · doi:10.1007/12_023 · Cited by 124
Yang, Z., Wang, J., Lu, Q., Xu, J., Kobayashi, Y., Takakura, T., Takimoto, A., Yoshioka, T., Lian, C., Chen, C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1822 · Cited by 123
A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin
Schoemaker, N. E., van Kesteren, C., Rosing, H., Jansen, S., Swart, M., Lieverst, J. A., Fraier, D., Breda, M., Pellizzoni, C., Spinelli, R., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600516 · Cited by 122
Clinical pharmacology of polyethylene glycol-L-asparaginase.
Ho, D. H., Brown, N. S., Yen, A., Holmes, R., Keating, M. J., Abuchowski, A., Newman, R. A., & Krakoff, I. H. (1986) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08348-5 · Cited by 119
Pegylated Interferon Alfa-2b Treatment for Patients With Solid Tumors: A Phase I/II Study
Bukowski, R. M., Ernstoff, M. S., Gore, M. E., Nemunaitis, J. J., Amato, R. J., Gupta, S. K., & Tendler, C. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.051 · Cited by 117
Heyns, C. F., Simonin, M.-P., Grosgurin, P., Schall, R., Porchet, H. C., & for the South African Triptorelin Study Group (2003) · British Journal of Urology · doi:10.1046/j.1464-410x.2003.04308.x · Cited by 114
Duncan, R., Hume, I. C., Kopečková, P., Ulbrich, K., Strohalm, J., & Kopec̆ek, J. (1989) · Journal of Controlled Release · doi:10.1016/0168-3659(89)90017-5 · Cited by 111
Self-citationFang, J. Q., Sawa, T., Akaike, T., & Maeda, H. (2002) · PubMed · Cited by 110
The Synthesis and Testing of Anti-Cancer Therapeutic Nanodevices
Baker, J. R., Quintana, A., Piehler, L. T., Banazak-Holl, M., Tomalia, D. A., & Raczka, E. (2001) · Biomedical Microdevices · doi:10.1023/a:1011485622697 · Cited by 107
Krinick, N. L., Sun, Y., Joyner, D. A., Spikes, J. D., Straight, R. C., & Kopeček, J. (1994) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856294x00040 · Cited by 106
Shiah, J.-G., Sun, Y., Kopečková, P., Peterson, C. M., Straight, R. C., & Kopec̆ek, J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00325-x · Cited by 105
Li, C., Shi, K., Wu, Q., Tansey, W., Hunter, N. R., Buchmiller, L., Milas, L., Charnsangavej, C., & Wallace, S. (2000) · PubMed · Cited by 102
Duncan, R., Cable, H. C., Lloyd, J. B., Rejmanová, P., & Kopec̆ek, J. (1982) · Bioscience Reports · doi:10.1007/bf01122173 · Cited by 101
Self-citationPolymeric Drug Delivery Systems
(2005) · CRC Press eBooks · doi:10.1201/9780849348129 · Cited by 98
Satchi‐Fainaro, R., Hailu, H., Davies, J. W., Summerford, C., & Duncan, R. (2003) · Bioconjugate Chemistry · doi:10.1021/bc020091k · Cited by 94
Self-citationTanaka, H., Satake-Ishikawa, R., Ishikawa, M., Matsuki, S., & Asano, K. (1991) · PubMed · Cited by 90
Estrogen modulation of osteoclast lysosomal enzyme secretion
Kremer, M., Judd, J., Rifkin, B. R., Auszmann, J. M., & Oursler, M. J. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240570211 · Cited by 83
Thomson, A. H., Vasey, P. A., Murray, L. S., Cassidy, J., Fraier, D., Frigerio, E., & Twelves, C. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690657 · Cited by 81
Tyrosinamide residues enhance pinocytic capture of N-(2-hydroxypropyl)methacrylamide copolymers
Duncan, R., Cable, H. C., Rejmanová, P., Kopec̆ek, J., & LLOYD, J. (1984) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(84)90320-9 · Cited by 81
Self-citationSynthetic biologically active polymers
Donaruma, L. G. (1975) · Progress in Polymer Science · doi:10.1016/0079-6700(75)90002-7 · Cited by 81
IHOVA, B. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00235-9 · Cited by 77
Duncan, R., Pratten, M. K., Cable, H. C., et al. (1981) · Biochemical Journal · doi:10.1042/bj1960049 · Cited by 75
Self-citationShibata, H., Yoshioka, Y., Ikemizu, S., Kobayashi, K., Yamamoto, Y., Mukai, Y., Okamoto, T., Taniai, M., Kawamura, M., Abe, Y., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0770 · Cited by 74
Gianasi, E., Buckley, R. G., Latigo, J. R., Wasil, M., & Duncan, R. (2002) · Journal of drug targeting · doi:10.1080/1061186021000072456 · Cited by 64
Self-citationŠťastný, M., Strohalm, J., Plocová, D., Ulbrich, K., & Řı́hová, B. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00373-6 · Cited by 61
Satchi‐Fainaro, R., & Duncan, R. (2005) · Advances in polymer science · doi:10.1007/11547785 · Cited by 59
Self-citationHandbook of Anticancer Drug Development
Budman, D. R., Calvert, H., Rowinsky, E. K., & Hill, B. T. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200411000-00011 · Cited by 55
HUANG, S. F., Kim, S., Lee, A. T., Karashima, T., Bucana, C., Kedar, D. J., Sweeney, P., Mian, B. M., Fan, D., Shepherd, D. L., et al. (2002) · PubMed · Cited by 54
Zimmerman, R. J., Aukerman, S. L., Katre, N. V., Winkelhake, J. L., & Young, D. (1989) · PubMed · Cited by 54
pH-sensitive hemolysis by random copolymers of alkyl acrylates and acrylic acid
Murthy, N., Chang, I., Stayton, P. S., & Hoffman, A. S. (2001) · Macromolecular Symposia · doi:10.1002/1521-3900(200107)172:1<35::aid-masy35>3.0.co;2-n · Cited by 53
Review : Synthetic Polymers with Intrinsic Anticancer Activity
Seymour, L. (1991) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159100600205 · Cited by 53
Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs
Říhová, B., Strohalm, J., Kubáčková, K., Jelínková, M., Hovorka, O., Kovář, M., Plocová, D., Šírová, M., Šťastný, M., Rozprimová, L., et al. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00489-8 · Cited by 49
CT-2103: A Novel Macromolecular Taxane with Potential Advantages Compared with Conventional Taxanes
Langer, C. J. (2004) · Clinical Lung Cancer · doi:10.3816/clc.2004.s.020 · Cited by 46
N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates
Duncan, R. (2005) · CRC Press eBooks · doi:10.1201/9780849348129-4 · Cited by 44
Self-citationHPMA copolymer–aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines
Greco, F., Vicent, M. J., Penning, N. A., Nicholson, R. I., & Duncan, R. (2005) · Journal of drug targeting · doi:10.1080/10611860500383788 · Cited by 36
Self-citationMccormick-Thomson, L. A., Seymour, L. C. W., Duncan, R., & Kopec̆ek, J. (1986) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391158600100102 · Cited by 35
Self-citationTransarterial Chemotherapy with Zinostatin Stimalamer for Hepatocellular Carcinoma
Okusaka, T., Okada, S., Ishii, H., Ikeda, M., Nakasuka, H., Nagahama, H., Iwata, R., Furukawa, H., Takayasu, K., Nakanishi, Y., et al. (1998) · Oncology · doi:10.1159/000011863 · Cited by 28
Langer, C. J., Socinski, M. A., & O'Byrne, K. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.lba7011 · Cited by 28
Phase I study of CT-2106 (polyglutamate camptothecin) in patients with advanced malignancies
Springett, G. M., Takimoto, C. H. M., McNamara, M., Doroshow, J. H., Syed, S. S., Eastham, E., Spriggs, D. R., Pezzulli, S., Michelson, G. C., & Dupont, J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.3127 · Cited by 24
Targeting and Intracellular Delivery of Drugs
Duncan, R. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200500014 · Cited by 23
Self-citationTargeting Chemotherapy of Hepatocellular Carcinoma
Konno, T., & Maeda, H. (1987) · Springer eBooks · doi:10.1007/978-4-431-68349-0_27 · Cited by 22
Ishii, H. (2003) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyg106 · Cited by 19
Boddy, A., Todd, R., Verrill, M., Sludden, J., Fishwick, K., Robson, L., Cassidy, J., Bisset, D., Garzone, P., & Calvert, A. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80747-x · Cited by 18
Delman, K. A., Brown, T. D., Thomas, M., Ensor, M., Holtsberg, F. W., Bomalaski, J. S., Clark, M. A., & Curley, S. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.4139 · Cited by 17
Cheng, P., Lo, T. W.-H., Leung, T.-W., Lam, A. T., & Lam, W.-M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.3179 · Cited by 9
Phase I and pharmacological study of CT-2103, a poly(L-glutamic acid)-paclitaxel conjugate
Todd, R., BODDY, A., Verrill, M., Sludden, J., Griffin, M., Elliott, S., Fishwick, K., Robson, L., Cassidy, J., Main, M., et al. (2001) · UCL Discovery (University College London) · doi:10.25405/ncl.34646574 · Cited by 9
Flaherty, L. E., Heilbrun, L. K., Marsack, C., & Vaishampayan, U. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.7562 · Cited by 2
Washart, M. L., Ryan, D. P., Lynch, T. J., Wang, Z., Appleman, L. J., Shapiro, G. I., Clark, J. W., Magrogan, L., Trapnell, C. B., & Eder, J. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.2088 · Cited by 2
Cited by
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Metadata
- Authors
- Duncan, R.
- Venue
- Nature Reviews Cancer
- Published
- 2006-08-10
- Volume
- 6
- Issue
- 9
- Pages
- 688-701
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2024787650
- Cited by
- 1,962
- References
- 126
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.